Summary
Rosana Kapeller, CEO of Rome Therapeutics, and Marty Taylor, physician-scientist at Harvard Medical School, join Vineeta Agarwala, general partner, and Bryan Faust, investment partner at a16z Bio + Health. Together, they discuss Rosana and Marty’s recent publication regarding a virus-like element in our genome known as LINE-1. LINE-1, part of our “dark genome,” was ignored......